These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6120776)

  • 1. Gastric acid inhibition and oxmetidine kinetics in duodenal ulcer.
    Gugler R; Rohner HG; Somogyi AA
    Clin Pharmacol Ther; 1982 Apr; 31(4):501-8. PubMed ID: 6120776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of etintidine in patients with duodenal ulcer.
    Brater DC; Meyers WM; Dandekar KA; Pittman KA; Peterson W
    Eur J Clin Pharmacol; 1982; 23(6):495-500. PubMed ID: 6130952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.
    Mills JG; Brunet PL; Griffiths R; Hunt RH; Vincent D; Milton-Thompson GJ; Burland WL
    Gut; 1982 Feb; 23(2):157-63. PubMed ID: 6121744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses.
    Jönsson KA; Bodemar G; Gotthard R; Norlander B; Walan A
    Eur J Clin Pharmacol; 1983; 24(3):353-6. PubMed ID: 6134622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxmetidine--a new H2-receptor antagonist].
    Gugler R
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1809-11. PubMed ID: 6641532
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist.
    Jones DB; Howden CW; Burget DW; Silletti C; Hunt RH
    Gut; 1988 Jul; 29(7):890-3. PubMed ID: 2969357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine.
    Gugler R; Rohner HG; Kratochvil P; Brandstätter G; Schmitz H
    Gut; 1982 Oct; 23(10):866-71. PubMed ID: 6126423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
    Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
    Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotidine, a new H2-receptor antagonist, is a potent inhibitor of nocturnal acid secretion in duodenal ulcer patients.
    Valenzuela JE; Strecker RB; Douglas AP
    Dig Dis Sci; 1981 May; 26(5):433-7. PubMed ID: 6113920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal gastric acid secretion in duodenal ulcer: inhibition by cimetidine.
    Broor SL; Shrestha GP; Mehta SK; Sharma BK
    Am J Med Sci; 1981; 282(3):120-4. PubMed ID: 6797298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing healing of duodenal ulcer. Control of nocturnal secretion by H2 blockade and characteristics of patients who failed to heal.
    Lam SK; Lai CL; Lee LN; Fok KH; Ng MM; Siu KF
    Dig Dis Sci; 1985 Jan; 30(1):45-51. PubMed ID: 2856903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxmetidine in the short term treatment of active duodenal ulcer. A review and commentary.
    Dobrilla G; de Pretis G; Chilovi F; Comberlato M
    Scand J Gastroenterol Suppl; 1989; 167():71-80. PubMed ID: 2575788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric acid secretion stimulated by modified sham-feeding, and the effects of histamine H2-antagonist and anti-muscarinic agent in patients with duodenal ulcer.
    Ooi S; Kaneko E
    Gastroenterol Jpn; 1989 Oct; 24(5):505-11. PubMed ID: 2572505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous nizatidine kinetics and acid suppression.
    Callaghan JT; Bergstrom RF; Obermeyer BD; King EP; Offen WW
    Clin Pharmacol Ther; 1985 Feb; 37(2):162-5. PubMed ID: 2857117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cimetidine on gastric secretion and duodenogastric reflux.
    Melville RJ; Suleiman SI; Whitfield PF; Parkin JV; Nwabunike TO; Hobsley M
    Gut; 1985 Aug; 26(8):766-9. PubMed ID: 4018640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxmetidine (SK&F 92994): pharmacokinetic study in patients with in patients with liver cirrhosis.
    Miglio F; Baraldini M; Serra S; Facchini A; Stefanini GF; Meliconi R; Gasbarrini G; Labo' G
    Int J Clin Pharmacol Res; 1985; 5(6):399-404. PubMed ID: 2869000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of oxmetidine and cimetidine in the treatment of duodenal ulcer.
    Barbezat GO; Brown D; Schlup M; Maclaurin BP
    N Z Med J; 1983 Apr; 96(729):250-2. PubMed ID: 6340009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of famotidine.
    Smith JL
    Digestion; 1985; 32 Suppl 1():15-23. PubMed ID: 2866132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.